Loopbaan van William R. Shanahan
Eerdere bekende functies van William R. Shanahan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-08-2016 | 15-04-2018 |
| ARENA PHARMACEUTICALS | Hoofd Techniek/Wetenschap/O&O | 01-03-2004 | 13-06-2016 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Hoofd Techniek/Wetenschap/O&O | 01-08-2000 | 01-03-2004 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-1994 | 01-08-2000 |
| PFIZER, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1990 | 01-01-1994 |
| Searle Research & Development | Hoofd Techniek/Wetenschap/O&O | 01-01-1986 | 01-01-1989 |
| University of Connecticut | Corporate Officer/Principal | - | - |
Opleiding van William R. Shanahan
| Dartmouth College | Undergraduate Degree |
| Loyola University of Chicago | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 11 |
Operationeel
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Searle Research & Development |
- Beurs
- Insiders
- William R. Shanahan
- Ervaring
